Lung cancer screening with low-dose CT integrated with pulmonary care in a public hospital in southern Brazil: results from the first 712 patients
Authors:
- Fábio Munhoz SvartmanFSFábio Munhoz Svartman
- Maurício Mello Roux LeiteMLMaurício Mello Roux Leite
- Ana Paula Garcia SartoriASAna Paula Garcia Sartori
- Renato Soares GutierrezRGRenato Soares Gutierrez
- Ana Carolina CadoreACAna Carolina Cadore
- Carla Tatiana Martins de OliveiraCOCarla Tatiana Martins de Oliveira
- Renata Ullmann de BritoRBRenata Ullmann de Brito
- Cristiano Feijó AndradeCACristiano Feijó Andrade
Open Access
- 28 September 2022
- journal article
- research article
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (5) , e20220146
Abstract
Objective: To describe the performance of a pulmonologist-led lung cancer screening pro-gram using low dose CT (LDCT) in a cohort of outpatients with stable respiratory diseases in the Brazilian public health care system. Methods: This was a retrospective analysis of the first two rounds of lung cancer screening of patients enrolled in the program. Inclusion criteria were being between 55 and 80 years of age, being a current or former smoker (smoking cessation = 15 years), and having a smoking history = 30 pack-years. LDCT results were interpreted in accordance with the Lung CT Screening Reporting and Data System, and those with a score of 3 or 4 were considered posi-tive screening. Incidental pleuropulmonary findings were sought in all reports. Results: LDCTs were requested for 791 patients during the study period, and 712 patients (90%) met the screening criteria. The mean patient age was 63 years, and most participants were current smokers (56%) with emphysema (78.5%) and other pleuropulmonary findings on CT (64%). Screening was positive in 14.0% and 5.6% of the cases in the first and second screening rounds, respectively. Lung cancer was detected in 1.5% of the patients in both first and second rounds (positive predictive value: 11.0% and 26.6%, respectively). The rate of early-stage (TNM I or II) screen-detected non-small cell carcinoma was 64.3%. Of the patients with positive screening, 19% were lost to follow-up before investigation was complete. Conclusions: The results of this screening program suggest its adequate performance in a cohort of patients with significant respiratory morbidity. The loss to follow-up rate highlights the need for constant monitoring and interventions to ensure adherence.Keywords
This publication has 34 references indexed in Scilit:
- Challenges in Lung Cancer Screening in Latin AmericaJournal of Global Oncology, 2018
- Lung cancer in BrazilJornal Brasileiro de Pneumologia, 2018
- Brazilian guidelines for the clinical management of paracoccidioidomycosisRevista da Sociedade Brasileira de Medicina Tropical, 2017
- Do Current Lung Cancer Screening Guidelines Apply for Populations With High Prevalence of Granulomatous Disease? Results From the First Brazilian Lung Cancer Screening Trial (BRELT1)The Annals of Thoracic Surgery, 2016
- Performance of Lung-RADS in the National Lung Screening TrialAnnals of Internal Medicine, 2015
- ACR–STR Practice Parameter for the Performance and Reporting of Lung Cancer Screening Thoracic Computed Tomography (CT)Journal of Thoracic Imaging, 2014
- Long-term Effect of Depot Medroxyprogesterone Acetate on Vaginal Microbiota, Epithelial Thickness and HIV Target CellsThe Journal of Infectious Diseases, 2014
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Use of mass media campaigns to change health behaviourThe Lancet, 2010
- The effects of television viewing in Greece, and the role of the paediatrician: a familiar triangle revisitedEuropean Journal of Pediatrics, 1996